Lead-induced procoagulant activation of erythrocytes through phosphatidylserine exposure may lead to thrombotic diseases

Chemical Research in Toxicology

Volumn 20, Issue 1, 2007, Pages 38-43

  Shin, Jung Hun ^a   Lim, Kyung Min ^a   Noh, Ji Yoon ^a   Bae, Ok Nam ^a   Chung, Seung Min ^a   Lee, Moo Yeol ^a   Chung, Jin Ho ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BLOOD CLOTTING FACTOR 10A; CALCIUM; LEAD; PHOSPHATIDYLSERINE; PROCOAGULANT; SCRAMBLASE; THROMBIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; CALCIUM CELL LEVEL; ENZYME ACTIVITY; ENZYME ASSAY; ERYTHROCYTE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEAD BLOOD LEVEL; MALE; NONHUMAN; NORMAL HUMAN; RAT; THROMBOSIS;

ADOLESCENT; ADULT; ANIMALS; COAGULANTS; DISEASE MODELS, ANIMAL; ERYTHROCYTES; HUMANS; LEAD; MALE; PHOSPHATIDYLSERINES; RATS; RATS, SPRAGUE-DAWLEY; THROMBOSIS;

RATTUS;

EID: 33846872535     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx060114+     Document Type: Article

References (36)

1. CDCP. (1997) Screening Young Children for Lead Poisoning: Guidance for State and Local Public Health Officials. US Department of Health and Human Services, Public Health Service, Atlanta, GA.
2. Goyer, R. A. (1993) Lead toxicity: current concerns. Environ. Health. Perspect. 100, 177-187.
3. Goyer, R. A., and Clarkson, T. W. (2001) Toxic Effects of Metals. In Casarett and Doull's Toxicology: The Basic Science of Poisons. (Klaassen, C. D., Ed.) pp 829, McGraw-Hill, New York.
4. Lustberg, M., and Silbergeld, E. (2002) Blood lead levels and mortality. Arch. Intern. Med. 162, 2443-2449.
5. Nash, D., Magder, L., Lustberg, M., Sherwin, R. W., Rubin, R. J., Kaufmann, R. B., and Silbergeld, E. K. (2003) Blood lead, blood pressure, and hypertension in perimenopausal and postmenopausal women. JAMA 289, 1523-1532.
6. Telisman, S., Pizent, A., Jurasovic, J., and Cvitkovic, P. (2004) Lead effect on blood pressure in moderately lead-exposed male workers. Am. J. Ind. Med. 45, 446-454.
7. Ding, Y., Vaziri, N. D., and Gonick, H. C. (1998) Lead-induced hypertension. II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside. Environ. Res. 76, 107-113.
8. Kaji, T., Yamamoto, C., Sakamoto, M., and Kozuka, H. (1992) Inhibitory effect of lead on the release of tissue plasminogen activator from human vascular endothelial cells in culture. Toxicology 73, 219-227.
9. Navas-Acien, A., Selvin, E., Sharrett, A. R., Calderon-Aranda, E., Silbergeld, E., and Guallar, E. (2004) Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation 109, 3196-3201.
10. Battistini, V., Morrow, J. J., Ginsburg, D., Thompson, G., Moore, M. R., and Goldberg, A. (1971) Erythrocyte delta-aminolaevulic acid dehydrase activity in anaemia. Br. J. Haematol. 20, 177-184.
11. Fukumoto, K., Karai, I., and Horiguchi, S. (1983) Effect of lead on erythrocyte membranes. Br. J. Ind. Med. 40, 220-223.
12. Monteiro, H. P., Abdalla, D. S., Augusto, O., and Bechara, E. J. (1989) Free radical generation during delta-aminolevulinic acid autoxidation: induction by hemoglobin and connections with porphyrinpathies. Arch. Biochem. Biophys. 271, 206-216.
13. Waldron, H. A. (1966) The anaemia of lead poisoning: a review. Br. J. Ind. Med. 23, 83-100.
14. Gurer, H., Ozgunes, H., Neal, R., Spitz, D. R., and Ercal, N. (1998) Antioxidant effects of N-acetylcysteine and succimer in red blood cells from lead-exposed rats. Toxicology 128, 181-189.
15. Quinlan, G. J., Halliwell, B., Moorhouse, C. P., and Gutteridge, J. M. (1988) Action of lead(II) and aluminium (III) ions on iron-stimulated lipid peroxidation in liposomes, erythrocytes and rat liver microsomal fractions. Biochim. Biophys. Acta 962, 196-200.
16. Ito, Y., Niiya, Y., Kurita, H., Shima, S., and Sarai, S. (1985) Serum lipid peroxide level and blood superoxide dismutase activity in workers with occupational exposure to lead. Int. Arch. Occup. Environ. Health 56, 119-127.
17. Sugawara, E., Nakamura, K., Miyake, T., Fukumura, A., and Seki, Y. (1991) Lipid peroxidation and concentration of glutathione in erythrocytes from workers exposed to lead. Br. J. Ind. Med. 48, 239-242.
18. Kempe, D. S., Lang, P. A., Eisele, K., Klarl, B. A., Wieder, T., Huber, S. M., Duranton, C., and Lang, F. (2005) Stimulation of erythrocyte phosphatidylserine exposure by lead ions. Am. J. Physiol: Cell Physiol. 288, C396-C402.
19. Andrews, D. A., and Low, P. S. (1999) Role of red blood cells in thrombosis. Curr. Opin. Hematol. 6, 76-82.
20. Marcus, A. J. (1990) Thrombosis and inflammation as multicellular processes: pathophysiologic significance of transcellular metabolism. Blood 76, 1903-1907.
21. Zwaal, R. F., and Schreit, A. J. (1997) Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89, 1121-1132.
22. Zwaal, R. F., Comfurius, P., and Bevers, E. M. (2005) Surface exposure of phosphatidylserine in pathological cells. Cell. Mol. Life Sci. 62, 971-988.
23. Closse, C., Dachary-Prigent, J., and Boisseau, M. R. (1999) Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br. J. Haematol. 107, 300-302.
24. Nieuwland, R., Berckmans, R. J., Rotteveel-Eijkman, R. C., Maquelin, K. N., Roozendaal, K. J., Jansen, P. G., ten Have, K., Eijsman, L., Hack, C. E., and Sturk, A. (1997) Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 96, 3534-3541.
25. Ninomiya, H., Kawashima, Y., Hasegawa, Y., and Nagasawa, T. (1999) Complement-induced procoagulant alteration of red blood cell membranes with microvesicle formation in paroxysmal nocturnal haemoglobinuria (PNH): implication for thrombogenesis in PNH. Br. J. Haematol. 106, 224-231.
26. Levy, L. A., Murphy, E., and London, R. E. (1987) Synthesis and characterization of 19F NMR chelators for measurement of cytosolic free Ca. Am. J. Physiol. 252, C441-C449.
27. Peyrou, V., Lormeau, J. C., Herault, J. P., Gaich, C., Pfliegger, A. M., and Herbert, J. M. (1999) Contribution of erythrocytes to thrombin generation in whole blood. Thromb. Haemostasis 81, 400-406.
28. 2+]i in cultured osteoblastic bone cells. Environ. Health Perspect. 84, 99-106.
29. Daleke, D. L., and Lyles, J. V. (2000) Identification and purification of aminophospholipid flippases. Biochim. Biophys. Acta 1486, 108-127.
30. Valles, J., Santos, M. T., Aznar, J., Martinez, M., Moscardo, A., Pinon, M., Broekman, M. J., and Marcus, A. J. (2002) Platelet-erythrocyte interactions enhance alpha(IIb)beta(3) integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivo. Blood 99, 3978-3984.
31. Bonomini, M., Sirolli, V., Settefrati, N., Dottori, S., Di Liberato, L., and Arduini, A. (1999) Increased erythrocyte phosphatidylserine exposure in chronic renal failure. J. Am. Soc. Nephrol. 10, 1982-1990.
32. Wood, B. L., Gibson, D. F., and Tait, J. F. (1996) Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood 88, 1873-1880.
33. 2+ in young and old human erythrocytes using 19F-NMR spectroscopy. Biochim. Biophys. Acta 1136, 155-160.
34. 2+ concentration, and detection of complexes with protein in erythrocytes. NMR Biomed. 7, 330-338.
35. 2+ by 19F NMR. Proc. Natl. Acad. Sci. U.S.A. 86, 5133-5135.
36. Dowd, T. L., and Gupta, R. K. (1991) 19F-NMR study of the effect of lead on intracellular free calcium in human platelets. Biochim. Biophys. Acta 1092, 341-346.